drugset / Trial / NCT00449904
Open-Label Phase III Long-Term Safety Trial of Liprotamase
RandomizedSingle-groupOpen-labelTreatment
Summary
This is an open-label, single-arm clinical study investigating the long-term safety of ALTU-135 treatment in patients with cystic fibrosis (CF)-related exocrine pancreatic insufficiency (PI).
Timeline
- Start
- 2007-06
- Primary completion
- 2009-04
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liprotamase | Protein / enzyme biologic | — | Oral |